Tag: university
-
Laser Images, A.I. Diagnose Brain Tumors
Results of a clinical trial show laser images analyzed by machine learning algorithms can offer near real-time diagnosis of brain tumor tissue during surgery.
-
Guidelines Proposed for Complex Clinical Trials
A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time.
-
Epilepsy Stimulation Device Detects Other Brain Disorders
An implanted device that stimulates areas of the brain associated with seizures can detect other neurological diseases in people with epilepsy.
-
High Innovation in Rural Regions, Not Just Cities
An analysis of supply-chain interactions by businesses in the U.S. shows many more areas of the country create better products and processes than previously believed.
-
Artificial Pancreas System Cleared by FDA
A system for automatically measuring blood glucose levels and dispensing insulin for people with type 1 diabetes is authorized by the Food and Drug Administration.
-
Science & Enterprise Year in Review
Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Climate Action Cost Accounting Standard Proposed
A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions.
-
Human Tooth Tissue Modeled in Chip Device
Dentistry researchers created a model of a tooth that simulates on a plastic slide the architecture and dynamic stresses in human teeth.
-
Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.